Lectus Therapeutics - Pharmaceutical Assets - Ownership and Business Overview

Life ScienceCompany

Lectus Therapeutics - Pharmaceutical Assets Ownership

Who owns Lectus Therapeutics - Pharmaceutical Assets?

Lectus Therapeutics - Pharmaceutical Assets is owned by UCB S.A.. It was acquired on November 22, 2011.

Lectus Therapeutics - Pharmaceutical Assets Business Overview

Where is Lectus Therapeutics - Pharmaceutical Assets headquartered?

Lectus Therapeutics - Pharmaceutical Assets is headquartered in United Kingdom.

What sector is Lectus Therapeutics - Pharmaceutical Assets in?

Lectus Therapeutics - Pharmaceutical Assets is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.

Acquired by UCB S.A. (Company) on 2011-11-22

Lectus Therapeutics - Pharmaceutical Assets

United Kingdom,

Lectus Therapeutics - Pharmaceutical Assets engages in the discovery and development of Lectus' drug for the treatment of central nervous system. LEPTICS technology to identify compounds in a new area of chemical space. Such compounds are anticipated to possess a novel mechanism of action mediated through an effect on ion channel accessory proteins.

Company Summary

SECTOR

Investor History
2011-11-22
Divestiture

UCB

Lectus Therapeutics Ltd.

Subscribe to unlock this and 209,748
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.6K Private Equity Firms
202K M&A Transactions
205K Companies Involved in M&A
(Buyer, Seller, or Target)
3.6K M&A Advisors
(Investment Banks and Law Firms)
81K M&A Contacts
(PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Lectus Therapeutics - Pharmaceutical Assets

Life Science Companies , United Kingdom Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United Kingdom Companies

Largest United Kingdom Companies , Acquisitive United Kingdom Companies , Recently Acquired United Kingdom Companies , Recently Sold United Kingdom Companies , Private United Kingdom Companies , Public United Kingdom Companies , Acquired United Kingdom Companies , PE Backed United Kingdom Companies